Sun Pharma to Acquire US-Based Checkpoint TherapeuticsÂ
India’s leading pharmaceutical company, Sun Pharmaceutical Industries, has announced the acquisition of Checkpoint Therapeutics, a U.S.-based biotechnology firm specialising in oncology. The deal is set to expand Sun Pharma’s oncology portfolio and strengthen its global presence in the rapidly growing cancer treatment market. Last year, the company signed a licensing agreement with Italian-Swiss firm Philogen…
Abdullah Ansari